WO2012059090A4 - Etacrynsäure zur verwendung bei der behandlung von lebensmittelempfindlichkeitsstörungen - Google Patents

Etacrynsäure zur verwendung bei der behandlung von lebensmittelempfindlichkeitsstörungen Download PDF

Info

Publication number
WO2012059090A4
WO2012059090A4 PCT/DE2011/001953 DE2011001953W WO2012059090A4 WO 2012059090 A4 WO2012059090 A4 WO 2012059090A4 DE 2011001953 W DE2011001953 W DE 2011001953W WO 2012059090 A4 WO2012059090 A4 WO 2012059090A4
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
etacrynic acid
food sensitivity
sensitivity disorders
acid
Prior art date
Application number
PCT/DE2011/001953
Other languages
English (en)
French (fr)
Other versions
WO2012059090A1 (de
Inventor
Martin Hils
Ralf Pasternack
Original Assignee
Zedira Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zedira Gmbh filed Critical Zedira Gmbh
Publication of WO2012059090A1 publication Critical patent/WO2012059090A1/de
Publication of WO2012059090A4 publication Critical patent/WO2012059090A4/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Erfindung betrifft die Verwendung von Etacrynsäure der Formel (I) zur Prophylaxe und Behandlung von Lebensmittelempfindlichkeitsstörungen, Lebensmittelunverträglichkeiten und Hauterkrankungen und insbesondere von Zöliakie sowie Zusammensetzungen enthaltend Etacryinsäure.

Claims

GEÄNDERTE ANSPRÜCHE beim Internationalen Büro eingegangen am 27 April 2012 (27.04.2012)
1. Verwendung der Etacrynsäure mit der Formel
Figure imgf000002_0001
sowie pharmakologisch verträgliche Salze oder Hydrate der Etacrynsäure zur Behandlung von Zöliakie.
GEÄNDERTES BLATT (ARTIKEL 19)
PCT/DE2011/001953 2010-11-03 2011-11-02 Etacrynsäure zur verwendung bei der behandlung von lebensmittelempfindlichkeitsstörungen WO2012059090A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010050449A DE102010050449A1 (de) 2010-11-03 2010-11-03 Verwendung von Etacrynsäure zur Behandlung von Lebensmittelempfindlichkeitsstörungen
DE102010050449.1 2010-11-03

Publications (2)

Publication Number Publication Date
WO2012059090A1 WO2012059090A1 (de) 2012-05-10
WO2012059090A4 true WO2012059090A4 (de) 2012-06-28

Family

ID=45528858

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2011/001953 WO2012059090A1 (de) 2010-11-03 2011-11-02 Etacrynsäure zur verwendung bei der behandlung von lebensmittelempfindlichkeitsstörungen

Country Status (2)

Country Link
DE (1) DE102010050449A1 (de)
WO (1) WO2012059090A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016379B2 (en) 2015-10-30 2018-07-10 Robin L. Webb Method of treatment for third spacing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686100A (en) * 1994-11-22 1997-11-11 E.R. Squibb & Sons, Inc. Prophylactic and therapeutic treatment of skin sensitization and irritation
US20040220264A1 (en) * 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
US20040265323A1 (en) * 2003-05-16 2004-12-30 Mccormick Beth A. Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin A3), inhibitors thereof and methods of use thereof
WO2009014624A2 (en) * 2007-07-20 2009-01-29 Johns Hopkins University Nrf2 inducers for treating epidermolysis bullosa simplex

Also Published As

Publication number Publication date
DE102010050449A1 (de) 2012-05-03
WO2012059090A1 (de) 2012-05-10

Similar Documents

Publication Publication Date Title
EP2418945A4 (de) Mineralsalz-schwefelsäure-zusammensetzungen und verfahren zu ihrer verwendung
EA020330B3 (ru) Хиназолиновые соединения
PH12015501965B1 (en) Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
UA110347C2 (uk) ПОХІДНІ 6-ЦИКЛОАЛКІЛ-1,5-ДИГІДРОПІРАЗОЛО[3,4-d]ПІРИМІДИН-4-ОНУ І ЇХ ЗАСТОСУВАННЯ ЯК ІНГІБІТОРІВ PDE9A
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
MA33939B1 (fr) 5-alcynyl-pyrimidines
MX2013011691A (es) Inhibidores de la replicacion viral, su proceso de preparacion y sus usos terapeuticos.
MX2011010908A (es) Anticuerpos anti-tnf-alfa y sus usos.
MX346336B (es) Derivados de quinazolin-4 (3h)-ona utilizados como inhibidores de pi3 cinasa.
MX2013005356A (es) Uso de fluopyram para combatir nematodos en cultivos.
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
TW200724532A (en) Pyrimidinecarboxylic acid derivatives and their use
MX2011013032A (es) Inhibidores de fosfatidilinositol 3-cinasa.
WO2009030224A3 (de) Neue chinazolin- verbindungen und ihre verwendung zur therapie von krebserkrankungen
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
WO2014141210A3 (en) Multifunctional immature dental pulp stem cells and therapeutic applications
CA2878796C (en) Derivatives of pyridinone as inhibitors for tissue transglutaminase
EP3747457A3 (de) Faktor-1-protein, faktor-2-protein und inhibitoren davon zur verwendung bei der behandlung und prävention von erkrankungen
EP4279128A3 (de) Neuartige antikörper mit bindung an tfpi und zusammensetzung damit
JOP20220152A1 (ar) مشتقات 3-(5- ميثوكسي -1- أوكسو أيزو إندولين -2- يل) بيبريدين -2، 6- دايون واستخداماتها
AU2011208681A8 (en) Aqueous solution comprising 3 - quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11811518

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 1120111042507

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11811518

Country of ref document: EP

Kind code of ref document: A1